Potential medicinal plants involved in inhibiting 3CLpro activity: A practical alternate approach to combating COVID-19Review article Published on 2022-08-012022-10-05 Journal: Journal of integrative medicine [Category] SARS, 변종, 치료제, [키워드] 3CLpro acute respiratory syndrome Angelica antiviral drug approach approved Camellia sinensis celastrol combating Compound compounds coronavirus Coronavirus 3C proteases coronavirus disease COVID-19 dose-dependent Drug development drugs Ecklonia cava effective facilitate gallate Glycosides Google Scholar help host cells IC50 inhibiting inhibitory concentration inhibitory effect involved less medicinal plants pharmacological target plant Plant-derived compounds Potential protease Replication Salvia miltiorrhiza SARS-CoV SARS-CoV-2 shown tested Torreya nucifera Treatment Vaccine variety Web of Science were used World Health Organization [DOI] 10.1016/j.joim.2022.08.001 [Article Type] Review article
Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation Research Published on 2021-07-152022-10-05 Journal: Acta pharmacologica Sinica [Category] COVID19(2023년), SARS, 바이오마커, 치료제, [키워드] ACE2 activated acute inflammatory response acute lung inflammation acute respiratory distress acute respiratory syndrome Administered administration AGT alleviate alteration antiviral activity Antiviral effect Cell controls coronavirus COVID-19 patient damaged EC50 entry of SARS-CoV-2 expressed expression HEK-293T cell in vitro in vivo induce infected with SARS-CoV-2 Infection inflammatory cell infiltration Inflammatory cytokines inhibit inhibited intravenous investigated low expression lung inflammatory response lung tissue mechanism mice Mortality mRNA level NF-κB Potential treatment progression respiratory inflammation Salvia miltiorrhiza SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 S syndrome target cells Therapeutics TLR4 treated Treatment VERO-E6 virus virus assay VSV-G [DOI] 10.1038/s41401-021-00714-4 [Article Type] Research
Application of Chinese Medicine in the Management of Critical Conditions: A Review on SepsisReview Published on 2020-01-012023-07-05 Journal: The American journal of Chinese medicine [Category] SARS, [키워드] Artemisinin Astragalus membranaceus baicalein berberine Chinese Herbal Formulation Cordyceps sinensis coronavirus disease-2019 (COVID-19) emodin Rhubarb Salvia miltiorrhiza sepsis. [DOI] 10.1142/S0192415X20500640 PMC 바로가기 [Article Type] Review